[Photo] Researchers Sweating It Out in COVID-19 Treatment Research
Countries around the world are racing to develop vaccines and treatments to overcome the novel coronavirus infection (COVID-19). The domestic bio venture company NGICAM Life Science has received approval for a new drug substance from the U.S. Food and Drug Administration (FDA) and is conducting Phase 2 clinical trials. Ahead of the new year 2021, a researcher is studying the COVID-19 treatment EC-18 at NGICAM Life Science's central research institute in Jecheon, Chungbuk./Reporter Kang Jin-hyung aymsdream@
Hot Picks Today
If They Fail Next Year, Bonus Drops to 97 Million Won... A Closer Look at Samsung Electronics DS Division’s 600M vs 460M vs 160M Performance Bonuses
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- Taking Vitamins for Health? The Hidden Dangers: Increased Risk of Stroke and Cancer
- Room Prices Soar from 60,000 to 760,000 Won and Sudden Cancellations: "We Won't Even Buy Water in Busan" — BTS Fans Outraged
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.